DGIdb - AKT2 Gene Record

AKT2 208 Druggable GenomeClinically Actionable

Alternate Names:

208
AKT SERINE/THREONINE KINASE 2
AKT2
HIHGHH
PKBB
PKBBETA
PRKBB
RAC-BETA
164731
392
ENSG00000105221
OTTHUMG00000137375
AKT2_HUMAN
P31751
RAC-BETA SERINE/THREONINE-PROTEIN KINASE
254
RAC-PK-beta
Protein kinase Akt-2
PKB beta
Protein kinase B beta
1480
NP_001617
NM_001243027
RAC-BETA SERINE/THREONINE-PROTEIN KINASE (EC 2.7.1.37) (RAC-PK-BETA) (PROTEIN KINASE AKT-2) (PROTEIN KINASE B, BETA) (PKB BETA). [SOURCE:UNIPROT/SWISSPROT;ACC:P31751]

Gene Info:

Interpro Name	Serine/threonine- / dual-specificity protein kinase, catalytic domain
Interpro Type	Domain
Uniprot Evidence	1: Evidence at protein level
Uniprot Status	Swiss-Prot
Human Readable Name	DRUGGABLE GENOME
Human Readable Name	KINASE
Interpro Acc	IPR002290
Interpro Short Name	Ser/Thr_dual-sp_kinase_dom
GuideToPharmacology Gene Category ID	285
Target Class	Enzymes
Target Subclass	EC:2.7.11.1
Gene Biotype	PROTEIN_CODING
GuideToPharmacology Gene Category Name	Akt (Protein kinase B, PKB) family

(17 More Sources)

Gene Categories: Category Details

TRANSPORTER
KINASE
SERINE THREONINE KINASE
DRUGGABLE GENOME
CLINICALLY ACTIONABLE
ENZYME
TRANSCRIPTION FACTOR

Publications:

Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.
Grell et al., 2012, Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab., Int. J. Oncol.

MIRANSERTIB AKT2

Interaction Score: 1.85

Interaction Types & Directionality:

allosteric modulator

inhibitor (inhibitory)

Interaction Info:

Specific Action of the Ligand Inhibition

Endogenous Drug? False

Direct Interaction? True

PMIDs:
None found

Sources:
ChemblInteractions GuideToPharmacology
IPATASERTIB AKT2

Interaction Score: 1.73

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

Specific Action of the Ligand Inhibition

PMIDs:
None found

Sources:
TdgClinicalTrial ClearityFoundationClinicalTrial ChemblInteractions GuideToPharmacology MyCancerGenomeClinicalTrial
BAY-1125976 AKT2

Interaction Score: 1.39

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT2 inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
AFURESERTIB AKT2

Interaction Score: 1.39

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

Specific Action of the Ligand Inhibition

PMIDs:
None found

Sources:
ChemblInteractions GuideToPharmacology
XL-418 AKT2

Interaction Score: 1.11

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name XL418

Novel drug target Novel Target

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions
TRICIRIBINE AKT2

Interaction Score: 1.11

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name triciribine-phosphate, TCN-P, VQD-002

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial ClearityFoundationClinicalTrial
MK-2206 AKT2

Interaction Score: 0.98

Interaction Types & Directionality:

allosteric modulator

inhibitor (inhibitory)

Interaction Info:

Specific Action of the Ligand Negative

Endogenous Drug? False

Direct Interaction? True

PMIDs:
None found

Sources:
TdgClinicalTrial ClearityFoundationClinicalTrial ChemblInteractions CGI GuideToPharmacology MyCancerGenomeClinicalTrial
AZD-5363 AKT2

Interaction Score: 0.92

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
TRICIRIBINE PHOSPHATE AKT2

Interaction Score: 0.92

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ARCHEXIN AKT2

Interaction Score: 0.92

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name RX-0201,Archexin

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial
MK-2201 AKT2

Interaction Score: 0.92

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs:
None found

Sources:
ChemblInteractions
UPROSERTIB AKT2

Interaction Score: 0.92

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Direct Interaction? True

Endogenous Drug? False

Specific Action of the Ligand Inhibition

PMIDs:
None found

Sources:
ChemblInteractions GuideToPharmacology
CAPIVASERTIB AKT2

Interaction Score: 0.62

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Specific Action of the Ligand Inhibition

Endogenous Drug? False

Direct Interaction? True

PMIDs:
None found

Sources:
ClearityFoundationClinicalTrial GuideToPharmacology
PERIFOSINE AKT2

Interaction Score: 0.55

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name perifosine, KRX-0401

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial
LY-2780301 AKT2

Interaction Score: 0.55

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs:
None found

Sources:
ChemblInteractions
A-443654 AKT2

Interaction Score: 0.43

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Specific Action of the Ligand Inhibition

Endogenous Drug? False

Direct Interaction? False

PMIDs:
10592235

Sources:
GuideToPharmacology
GSK-690693 AKT2

Interaction Score: 0.25

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

Specific Action of the Ligand Inhibition

PMIDs:
None found

Sources:
ChemblInteractions GuideToPharmacology
TRASTUZUMAB AKT2

Interaction Score: 0.23

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22842582

Sources:
CIViC
OMIPALISIB AKT2

Interaction Score: 0.15

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

PMIDs:
None found

Sources:
MyCancerGenomeClinicalTrial
LAUROGUADINE AKT2

Interaction Score: 0.1

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
EVEROLIMUS AKT2

Interaction Score: 0.07

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

PMIDs:
None found

Sources:
MyCancerGenomeClinicalTrial
GSK-269962A AKT2

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
SOTRASTAURIN AKT2

Interaction Score: 0.05

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC

Ensembl: ENSG00000105221
- Version: 101_38
Alternate Names:

AKT2 Ensembl Gene Name

Gene Info:

Gene Biotype PROTEIN_CODING

Publications:

RussLampel: ENSG00000105221

Version: 26-July-2011

Alternate Names:

AKT2 Display Id

RAC-BETA SERINE/THREONINE-PROTEIN KINASE (EC 2.7.1.37) (RAC-PK-BETA) (PROTEIN KINASE AKT-2) (PROTEIN KINASE B, BETA) (PKB BETA). [SOURCE:UNIPROT/SWISSPROT;ACC:P31751] Description

ENSG00000105221 Ensembl Gene Id

Gene Info:

Human Readable Name DRUGGABLE GENOME

Gene Categories:

DRUGGABLE GENOME

Publications:

TdgClinicalTrial: P31751
- Version: January-2014
Alternate Names:

AKT2 Gene Symbol

Gene Info:

Target Class Enzymes

Target Subclass EC:2.7.11.1

Publications:
HopkinsGroom: P31751
- Version: 11-September-2012
Alternate Names:

208 Entrez Gene Id

P31751 Uniprot Accession

ENSG00000105221 Ensembl Gene Id

Gene Info:

Interpro Name Serine/threonine- / dual-specificity protein kinase, catalytic domain

Interpro Type Domain

Uniprot Evidence 1: Evidence at protein level

Gene Categories:

KINASE, DRUGGABLE GENOME

Publications:
GuideToPharmacology: 208
- Version: 29-September-2020
Alternate Names:

392 HUGO Gene ID

392 HUGO Gene Symbol

AKT serine/threonine kinase 2 HUGO Gene Name

Gene Info:

GuideToPharmacology Gene Category Name Akt (Protein kinase B, PKB) family

GuideToPharmacology Gene Category ID 285

Gene Categories:

ENZYME

Publications:
CIViC: AKT2
- Version: 14-September-2020
Alternate Names:

208 Entrez Gene ID

254 CIViC Gene ID

Gene Info:

Publications:

Grell et al., 2012, Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab., Int. J. Oncol.
HingoraniCasas: ENSG00000105221
- Version: 31-May-2017
Alternate Names:

ENSG00000105221 Gene Symbol

AKT2 Ensembl Id

Gene Info:

Gene Categories:

DRUGGABLE GENOME

Publications:
ChemblInteractions: AKT2
- Version: chembl_23
Alternate Names:

AKT2 GENE_SYMBOL

RAC-beta serine/threonine-protein kinase UNIPROT

Protein kinase Akt-2 UNIPROT

Gene Info:

Publications:
HumanProteinAtlas: AKT2
- Version: 19.3
Alternate Names:

ENSG00000105221 Ensembl Gene ID

AKT serine/threonine kinase 2 Human Protein Atlas Gene Description

P31751 UniProt ID

Gene Info:

Gene Categories:

ENZYME

Publications:
Tempus: AKT2
- Version: 11-November-2018
Alternate Names:

AKT2 Gene Symbol

Gene Info:

Gene Categories:

CLINICALLY ACTIONABLE

Publications:
dGene: AKT2
- Version: 27-Jun-2013
Alternate Names:

208 Gene ID

HIHGHH dGene Synonym

PKBB dGene Synonym

Gene Info:

Gene Categories:

KINASE, SERINE THREONINE KINASE

Publications:
Pharos: AKT2
- Version: 01-May-2021
Alternate Names:

RAC-beta serine/threonine-protein kinase Gene Name

P31751 UniProt ID

Gene Info:

Gene Categories:

TRANSPORTER, KINASE, TRANSCRIPTION FACTOR

Publications:
CGI: AKT2
- Version: 27-September-2017
Alternate Names:

Gene Info:

Publications:
MskImpact: AKT2
- Version: May-2015
Alternate Names:

Gene Info:

Gene Categories:

CLINICALLY ACTIONABLE

Publications:
MyCancerGenomeClinicalTrial: AKT2
- Version: 30-February-2014
Alternate Names:

Gene Info:

Publications:
ClearityFoundationClinicalTrial: AKT2
- Version: 15-June-2013
Alternate Names:

Gene Info:

Publications:
DTC: AKT2
- Version: 02-September-2020
Alternate Names:

Gene Info:

Publications:
FoundationOneGenes: AKT2
- Version: 03-September-2020
Alternate Names:

Gene Info:

Gene Categories:

CLINICALLY ACTIONABLE

Publications:
CarisMolecularIntelligence: AKT2
- Version: 04-September-2020
Alternate Names:

Gene Info:

Gene Categories:

CLINICALLY ACTIONABLE

Publications:
Oncomine: AKT2
- Version: v3
Alternate Names:

Gene Info:

Gene Categories:

CLINICALLY ACTIONABLE

Publications:
GO: AKT2
- Version: 01-May-2021
Alternate Names:

Gene Info:

Gene Categories:

SERINE THREONINE KINASE

Publications:

Specific Action of the Ligand	Inhibition
Endogenous Drug?	False
Direct Interaction?	True

Mechanism of Interaction	Serine/threonine-protein kinase AKT inhibitor
Direct Interaction	yes
Specific Action of the Ligand	Inhibition

Mechanism of Interaction	Serine/threonine-protein kinase AKT2 inhibitor
Direct Interaction	yes

Trial Name	XL418
Novel drug target	Novel Target
Mechanism of Interaction	Serine/threonine-protein kinase AKT inhibitor

Trial Name	triciribine-phosphate, TCN-P, VQD-002
Novel drug target	Novel Target

Specific Action of the Ligand	Negative
Endogenous Drug?	False
Direct Interaction?	True

AKT2	Display Id
RAC-BETA SERINE/THREONINE-PROTEIN KINASE (EC 2.7.1.37) (RAC-PK-BETA) (PROTEIN KINASE AKT-2) (PROTEIN KINASE B, BETA) (PKB BETA). [SOURCE:UNIPROT/SWISSPROT;ACC:P31751]	Description
ENSG00000105221	Ensembl Gene Id

208	Entrez Gene Id
P31751	Uniprot Accession
ENSG00000105221	Ensembl Gene Id

392	HUGO Gene ID
392	HUGO Gene Symbol
AKT serine/threonine kinase 2	HUGO Gene Name

AKT2	GENE_SYMBOL
RAC-beta serine/threonine-protein kinase	UNIPROT
Protein kinase Akt-2	UNIPROT

allosteric modulator
inhibitor (inhibitory)

allosteric modulator
inhibitor (inhibitory)

RAC-beta serine/threonine-protein kinase	Gene Name
P31751	UniProt ID

AKT2 Gene Record

AKT2 208 Druggable GenomeClinically Actionable

Alternate Names:

Gene Info:

Gene Categories: Category Details

Publications:

Interaction Types & Directionality: allosteric modulator inhibitor (inhibitory)

Interaction Info: Specific Action of the Ligand Inhibition Endogenous Drug? False Direct Interaction? True

PMIDs: None found

Sources: ChemblInteractions GuideToPharmacology

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor Direct Interaction yes Specific Action of the Ligand Inhibition

PMIDs: None found

Sources: TdgClinicalTrial ClearityFoundationClinicalTrial ChemblInteractions GuideToPharmacology MyCancerGenomeClinicalTrial

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Serine/threonine-protein kinase AKT2 inhibitor Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor Direct Interaction yes Specific Action of the Ligand Inhibition

PMIDs: None found

Sources: ChemblInteractions GuideToPharmacology

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name XL418 Novel drug target Novel Target Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs: None found

Sources: TdgClinicalTrial ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info: Trial Name triciribine-phosphate, TCN-P, VQD-002 Novel drug target Novel Target

PMIDs: None found

Sources: TdgClinicalTrial ClearityFoundationClinicalTrial

Interaction Types & Directionality: allosteric modulator inhibitor (inhibitory)

Interaction Info: Specific Action of the Ligand Negative Endogenous Drug? False Direct Interaction? True

PMIDs: None found

Sources: TdgClinicalTrial ClearityFoundationClinicalTrial ChemblInteractions CGI GuideToPharmacology MyCancerGenomeClinicalTrial

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info: Trial Name RX-0201,Archexin Novel drug target Novel Target

PMIDs: None found

Sources: TdgClinicalTrial

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Direct Interaction yes Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Direct Interaction? True Endogenous Drug? False Specific Action of the Ligand Inhibition

PMIDs: None found

Sources: ChemblInteractions GuideToPharmacology

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Specific Action of the Ligand Inhibition Endogenous Drug? False Direct Interaction? True

PMIDs: None found

Sources: ClearityFoundationClinicalTrial GuideToPharmacology

Interaction Types & Directionality: n/a

Interaction Info: Trial Name perifosine, KRX-0401 Novel drug target Novel Target

PMIDs: None found

Sources: TdgClinicalTrial

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Direct Interaction yes Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Specific Action of the Ligand Inhibition Endogenous Drug? False Direct Interaction? False

PMIDs: 10592235

Sources: GuideToPharmacology

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor Direct Interaction yes Specific Action of the Ligand Inhibition

PMIDs: None found

Sources: ChemblInteractions GuideToPharmacology

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 22842582

Sources: CIViC

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info:

Interaction Types & Directionality:

allosteric modulator

inhibitor (inhibitory)

Interaction Info:

Specific Action of the Ligand Inhibition

Endogenous Drug? False

Direct Interaction? True

PMIDs:
None found

Sources:
ChemblInteractions GuideToPharmacology

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

Specific Action of the Ligand Inhibition

PMIDs:
None found

Sources:
TdgClinicalTrial ClearityFoundationClinicalTrial ChemblInteractions GuideToPharmacology MyCancerGenomeClinicalTrial

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT2 inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

Specific Action of the Ligand Inhibition

PMIDs:
None found

Sources:
ChemblInteractions GuideToPharmacology

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name XL418

Novel drug target Novel Target

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name triciribine-phosphate, TCN-P, VQD-002

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial ClearityFoundationClinicalTrial

Interaction Types & Directionality:

allosteric modulator

inhibitor (inhibitory)

Interaction Info:

Specific Action of the Ligand Negative

Endogenous Drug? False

Direct Interaction? True

PMIDs:
None found

Sources:
TdgClinicalTrial ClearityFoundationClinicalTrial ChemblInteractions CGI GuideToPharmacology MyCancerGenomeClinicalTrial

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name RX-0201,Archexin

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Direct Interaction? True

Endogenous Drug? False

Specific Action of the Ligand Inhibition

PMIDs:
None found

Sources:
ChemblInteractions GuideToPharmacology

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Specific Action of the Ligand Inhibition

Endogenous Drug? False

Direct Interaction? True

PMIDs:
None found

Sources:
ClearityFoundationClinicalTrial GuideToPharmacology

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name perifosine, KRX-0401

Novel drug target Novel Target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Specific Action of the Ligand Inhibition

Endogenous Drug? False

Direct Interaction? False

PMIDs:
10592235

Sources:
GuideToPharmacology

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Serine/threonine-protein kinase AKT inhibitor

Direct Interaction yes

Specific Action of the Ligand Inhibition

PMIDs:
None found

Sources:
ChemblInteractions GuideToPharmacology

Interaction Types & Directionality:

n/a

PMIDs:
22842582

Sources:
CIViC

Interaction Types & Directionality:

inhibitor (inhibitory)

PMIDs:
None found

Sources:
MyCancerGenomeClinicalTrial

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Interaction Types & Directionality:

inhibitor (inhibitory)

PMIDs:
None found

Sources:
MyCancerGenomeClinicalTrial